GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding.

MLA

Nayak, Tapan K., et al. “GPER-Targeted, 99mTc-Labeled, Nonsteroidal Ligands Demonstrate Selective Tumor Imaging and in Vivo Estrogen Binding.” Molecular Cancer Research : MCR, vol. 12, no. 11, Nov. 2014, pp. 1635–43. EBSCOhost, https://doi.org/10.1158/1541-7786.MCR-14-0289.

APA

Nayak, T. K., Ramesh, C., Hathaway, H. J., Norenberg, J. P., Arterburn, J. B., & Prossnitz, E. R. (2014). GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding. Molecular Cancer Research : MCR, 12(11), 1635–1643. https://doi.org/10.1158/1541-7786.MCR-14-0289

Chicago

Nayak, Tapan K, Chinnasamy Ramesh, Helen J Hathaway, Jeffrey P Norenberg, Jeffrey B Arterburn, and Eric R Prossnitz. 2014. “GPER-Targeted, 99mTc-Labeled, Nonsteroidal Ligands Demonstrate Selective Tumor Imaging and in Vivo Estrogen Binding.” Molecular Cancer Research : MCR 12 (11): 1635–43. doi:10.1158/1541-7786.MCR-14-0289.